Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 May 4;187(9):1383-93.
doi: 10.1084/jem.187.9.1383.

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes

Affiliations

Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes

A Gallimore et al. J Exp Med. .

Abstract

This study describes the construction of soluble major histocompatibility complexes consisting of the mouse class I molecule, H-2Db, chemically biotinylated beta2 microglobulin and a peptide epitope derived from the glycoprotein (GP; amino acids 33-41) of lymphocytic choriomeningitis virus (LCMV). Tetrameric class I complexes, which were produced by mixing the class I complexes with phycoerythrin-labeled neutravidin, permitted direct analysis of virus-specific cytotoxic T lymphocytes (CTLs) by flow cytometry. This technique was validated by (a) staining CD8+ cells in the spleens of transgenic mice that express a T cell receptor (TCR) specific for H-2Db in association with peptide GP33-41, and (b) by staining virus-specific CTLs in the cerebrospinal fluid of C57BL/6 (B6) mice that had been infected intracranially with LCMV-DOCILE. Staining of spleen cells isolated from B6 mice revealed that up to 40% of CD8(+) T cells were GP33 tetramer+ during the initial phase of LCMV infection. In contrast, GP33 tetramers did not stain CD8+ T cells isolated from the spleens of B6 mice that had been infected 2 mo previously with LCMV above the background levels found in naive mice. The fate of virus-specific CTLs was analyzed during the acute phase of infection in mice challenged both intracranially and intravenously with a high or low dose of LCMV-DOCILE. The results of the study show that the outcome of infection by LCMV is determined by antigen load alone. Furthermore, the data indicate that deletion of virus-specific CTLs in the presence of excessive antigen is preceded by TCR downregulation and is dependent upon perforin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Staining of GP33-specific H-2Db–restricted TCR transgenic T cells and polyclonal LCMV-specific CTL lines with GP33 tetramers. Spleen cells from a naive B6 mouse and a 318 TCR transgenic mouse were stained with monoclonal antibodies specific for CD8 and the TCR gene segment Vα2 (A and B) or with anti-CD8 and GP33 tetramers (C and D). CD8+ CTL lines specific for H-2Db–restricted LCMV peptide epitopes, GP33–41, NP396–404, and GP276–286 were stained using GP33 tetramers 2 wk after in vitro restimulation with peptide-pulsed spleen cells (E).
Figure 1
Figure 1
Staining of GP33-specific H-2Db–restricted TCR transgenic T cells and polyclonal LCMV-specific CTL lines with GP33 tetramers. Spleen cells from a naive B6 mouse and a 318 TCR transgenic mouse were stained with monoclonal antibodies specific for CD8 and the TCR gene segment Vα2 (A and B) or with anti-CD8 and GP33 tetramers (C and D). CD8+ CTL lines specific for H-2Db–restricted LCMV peptide epitopes, GP33–41, NP396–404, and GP276–286 were stained using GP33 tetramers 2 wk after in vitro restimulation with peptide-pulsed spleen cells (E).
Figure 2
Figure 2
Staining of GP33-specific Db-restricted CD8+ cells isolated from the CSF of mice infected intracranially with rVVINDG or LCMV-DOCILE. Cells isolated from the CSF of mice infected intracranially with 2 × 103 PFU of rVVINDG (A) or 30 PFU of LCMV-DOCILE (B) were stained with anti-CD8 antibodies and GP33 tetramers. The histograms show staining of live CD8+ cells with GP33 tetramers.
Figure 3
Figure 3
CD8+ and GP33-specific Db-restricted CD8+ cells isolated from the spleens of mice infected intravenously with LCMV-DOCILE. Cells isolated from the spleens of mice infected intravenously with low or high dose of LCMV-DOCILE were stained with anti-CD8 antibodies and GP33 tetramers. The graphs describe data collected from histograms generated as described in Fig. 2. Solid bars, the percentage of CD8+ cells in the spleens of individual mice at four time points during the acute phase of LCMV infection; open bars, the percentage of CD8+ cells that also stained with GP33 tetramers. The results are representative of two independent experiments carried out using groups of two mice. The number of GP33-specific CD8+ cells (× 105) are shown in brackets above each bar.
Figure 4
Figure 4
Cytotoxic activity and virus titers in mice infected intravenously with LCMV-DOCILE. LCMV-specific CTL activity was measured using spleen cells from mice that had been infected intravenously with a low (A–D) or high dose (E–H) of LCMV-DOCILE. Spleen cells were tested for lysis of normal MC57 cells (○) or MC57 cells that had either been pulsed with peptide GP33 (▴) or which had been infected with LCMV-DOCILE (•). Virus titers, measured as PFU in the spleen (Spl) and thymus (Thy) of each mouse are shown in the upper right-hand corner of each panel. 200 PFU represents the detection limit of the assay.
Figure 5
Figure 5
Intracellular cytokine staining of CD8+ cells isolated from naive and LCMV-DOCILE–infected B6 mice. Spleen cells isolated from naive mice were stained directly (A) or after stimulation with PMA and ionomycin (B) using anti-CD8 and anti–IFN-γ antibodies. Spleen cells recovered from mice infected 8 d before with a low dose (2 × 102 PFU intravenously) of LCMV-DOCILE were stimulated with PMA and ionomycin and subsequently stained with anti-CD8 antibodies, GP33 tetramers, and anti–IFN-γ antibodies. C represents IFN-γ staining of the gated CD8+ cell population, whereas D represents IFN-γ staining of the gated CD8+/tetramer+ cell population. The percentage of gated cells that express IFN-γ is shown in each panel.
Figure 6
Figure 6
Intracellular cytokine staining of CD8+ cells isolated from LCMV-DOCILE–infected B6 mice. Spleen cells recovered from mice that had been infected intravenously with either low- (2 × 102 PFU) or high-dose (2 × 106 PFU) LCMV-DOCILE were stimulated with PMA and ionomycin and subsequently stained with anti-CD8 antibodies, GP33 tetramers, and anti–IFN-γ antibodies. Subsequent FACS® analysis was carried out as described for Fig. 5. Solid bars, the percentage of CD8+/ GP33 tetramer+ cells (from the experiment shown in Fig. 3) recovered from the spleens of each mouse; open bars, the percentage of CD8+/GP33 tetramer+ cells that express IFN-γ.
Figure 7
Figure 7
Staining of GP33-specific CD8+ cells isolated from the CSF and spleens of mice infected intracranially with LCMV-DOCILE. Cells isolated from the CSF and spleens of mice infected with low (A, B, E, and F) or high (C, D, G, and H) doses intracranially with LCMV-DOCILE were stained with anti-CD8 antibodies and tetramers. (Left) Staining of live cells with anti-CD8 antibodies; (right) gated CD8+ cell population stained with GP33 tetramers. The percentage of CD8+ cells (A, C, E, and G) and the percentage of CD8+/tetramer+ cells (B, D, F, and H) is shown in each panel. The mean fluorescence of splenic GP33 tetramer–stained CD8+ T cells is shown in brackets in F and H. The results are representative of two independent experiments carried out using groups of two mice.
Figure 8
Figure 8
Cytotoxic activity and virus titers in mice infected intracranially with LCMV-DOCILE. LCMV-specific CTL activity was measured using spleen cells from mice that had been infected intracranially with a low (A) or high (B) dose of LCMV-DOCILE. Spleen cells were tested for lysis of normal MC57 cells (○), MC57 cells that had either been pulsed with peptide GP33 (▴), and MC57 cells which had been infected with LCMV-DOCILE (•). Virus titers, measured per spleen and brain of each mouse, are also shown.
Figure 9
Figure 9
Intracellular cytokine staining of CD8+ cells isolated from the spleens and CSF of mice infected intracranially with a low or high dose of LCMV-DOCILE. Spleen cells and CSF recovered from mice that had been infected intracranially with either low (30 PFU) or high (3 × 104 PFU) dose LCMV-DOCILE were stimulated with PMA and ionomycin and subsequently stained with anti-CD8 antibodies, GP33 tetramers, and anti–IFN-γ antibodies. Subsequent FACS® analysis was carried out as described for Fig. 5. (Left) CD8+ cells that express IFN-γ; (right) CD8+ GP33-specific T cells that express IFN-γ. The percentages of CD8+ and CD8+/tetramer+ cells (from the experiment shown in Fig. 7) that express IFN-γ are shown in each panel.
Figure 10
Figure 10
Staining of GP33-specific Db-restricted CD8+ cells isolated from the spleens of B6 and PKOB mice infected intravenously with LCMV-DOCILE. Cells isolated from the spleens of either B6 mice infected with a low dose of LCMV-DOCILE (A and D), PKOB mice infected with a low dose of LCMV-DOCILE (B and E), or B6 mice infected with a high dose of the same virus (C and F) were stained with anti-CD8 antibodies and GP33 tetramers. (Histograms) The gated CD8+ cell population stained with GP33 tetramers. The results are representative of two independent experiments carried out using groups of two mice.
Figure 11
Figure 11
Intracellular cytokine staining of CD8+ cells isolated from LCMV-infected PKOB mice. Spleen cells recovered from mice that had been infected intravenously with either low-dose (2 × 102 PFU) LCMV-DOCILE were stimulated with PMA and ionomycin and subsequently stained with anti-CD8 antibodies, GP33 tetramers, and anti–IFN-γ antibodies. Subsequent FACS® analysis was carried out as described for Fig. 5. (Left histograms) the percentage of CD8+ cells that express IFN-γ; (right histograms) the percentage of CD8+ GP33-specific T cells that express IFN-γ.

Similar articles

Cited by

References

    1. Zinkernagel RM, Doherty PC. Restriction of in vitroT cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature. 1974;248:701–702. - PubMed
    1. Townsend A, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 1986;44:959–968. - PubMed
    1. Morris AG, Lin YL, Askonas BA. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature. 1982;295:150–152. - PubMed
    1. Kündig TM, Hengartner H, Zinkernagel RM. T cell dependent interferon gamma exerts an antiviral effect in the central nervous system but not in peripheral sold organs. J Immunol. 1993;150:2316–2321. - PubMed
    1. Ruby J, Ramshaw I. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 1992;10:353–358. - PubMed

Publication types

MeSH terms